Surgery without radiotherapy for primary treatment of endometrial cancer

Obstetrics and Gynecology

Volumn 91, Issue 3, 1998, Pages 355-359

  Larson, Dale M ^a   Broste, Steven K ^a   Krawisz, Bruce R ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LIFE TABLES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032032199     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00698-4     Document Type: Article

References (19)

1. Creasman VVT. New gynecologic cancer staging. Obstet Gynecol 1990;75:287-8.
2. Boronow RC, Morrow CP, Creasman VVT, DiSaia PJ, Silverberg SB, Miller A, et al. Surgical staging in endometrial cancer: Clinicalpathologic findings of a prospective study. Obstet Gynecol 1984; 68:825-32.
3. DiSaia PJ, Creasman VVT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 1985;151:1009-15.
4. DiSaia PJ, Creasman VVT. Adenocarcinoma of the uterus. In: Clinical gynecologic oncology. 5th ed. St. Louis: Mosby, 1997:13467.
5. Barakat RR, Park RC, Grigsby PW, Muss HD, Morris HJ. Corpus: Epithelial tumors. In: Hoskins VVJ, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology. 2nd ed. Philadelphia: Lippincott-Raven, 1997:859-96.
6. Society of Gynecologic Oncologists. Clinical practice guidelines. Chicago: Society of Gynecologic Oncologists, 1996.
7. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
8. Greenwood M. The natural duration of cancer. Reports on public health and medical subjects. London: Her Majesty's Stationery Office 1926:33:1-26.
9. Larson DL, Johnson K, Olson KA. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: Morbidity and mortality. Obstet Gynecol 1992;79:998-1001. 10. Homesley HD, Kadar N, Barrett RJ, Lentz SS. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial adenocarcinoma. Am J Obstet Gynecol 1992;167:1225-30.
10. Zorlu CG, Kuscu E, Ergon Y, Aydogdu T, Cobanoglu O, Erdas O. Intraoperative evaluation of prognostic factors in stage I endometrial cancer by frozen section: How reliable? Obstet Gynecol Scand 1993,72:382-5.
11. Larson DM, Johnson KK, Reyes CN, Broste SK. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol 1994;84:399-403.
12. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88:394-8.
13. Larson DM, Johnson KK, Broste SK, Krawicz BR, KresI JJ. Comparison of D & C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995; 86:38-42.
14. Takeshima N, Hirai Y, Tanaka N, Yamawaki T, Yamauchi K, Hasumi K. Pelvic lymph node métastases in endometrial cancer with no myometrial invasion. Obstet Gynecol 1996;88:280-2.
15. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F, et al. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995 6:29-33.
16. Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, et al. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high risk endometrial carcinoma. Gynecol Oncol 1994;55:47-50.
17. Morrow CP, Bundy BN, Kumar RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. A Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
18. Polish RA, Twiggs LB, Adcock LL, Savage JE, Levitt SH, Prem KA, Para-aortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 1985 4:251-6.
19. Jones HW. Treatment of adenocarcinoma of the endometrium. Obstet Gynecol Surv 1975 0:147-69.